Reply to Watkins and Rukazenkov (J Cell Mol Med 2010), re-Letter of Response to manuscript entitled 'Clinical outcomes in NSCLC patients with EGFR mutations: Pooled analysis' (Paz-Ares et al., J Cell Mol Med. 2010; 14(1-2): 51-69)

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 5, 2011, Pages 1225-

  Paz Ares, Luis ^a   Moecks, Joachim ^a   Klughammer, Barbara ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN KINASE INHIBITOR;

GENETICS; HUMAN; LETTER; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MUTATION;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; MUTATION; PROTEIN KINASE INHIBITORS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 79957609256     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2011.01295.x     Document Type: Letter

References (0)